STWX:SW:SW-SPDR® MSCI Europe Health Care UCITS ETF CHF (CHF)

ETF | Others |

Last Closing

USD 215.4

Change

+4.30 (+2.04)%

Market Cap

USD 0.64B

Volume

233.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XLDX:SW Xtrackers LevDAX Daily Swap UC..

-1.60 (-0.88%)

USD 411,075.38B
XNIF:SW Xtrackers Nifty 50 Swap UCITS ..

-2.40 (-0.99%)

USD 292,109.69B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

-56.00 (-0.78%)

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

-14.50 (-0.30%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

-2.00 (-0.13%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

-8.00 (-0.39%)

USD 134,034.85B
SX7EEX:SW iShares EURO STOXX Banks 30-15..

-0.18 (-1.19%)

USD 6,289.31B
TDXPEX:SW iShares TecDAX® UCITS ETF (DE..

-0.43 (-1.42%)

USD 5,933.97B
SMIEX:SW iShares SLI UCITS ETF (DE)

-0.70 (-0.51%)

USD 5,933.96B
DJSXE:SW iShares Core EURO STOXX 50 UCI..

N/A

USD 5,933.96B

ETFs Containing STWX:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.29% 86% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.29% 86% B+ 86% B+
Trailing 12 Months  
Capital Gain 6.74% 44% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.74% 43% F 47% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.73% 49% F 50% F
Dividend Return 1.73% 49% F 49% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 3.55% 67% D+ 72% C
Risk Adjusted Return 48.61% 54% F 57% F
Market Capitalization 0.64B 70% C- 66% D+

Annual Financials (CHF)

Quarterly Financials (CHF)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.